Literature DB >> 21497741

Fibrosis in alcoholic and nonalcoholic steatohepatitis.

Ramon Bataller1, Krista Rombouts, José Altamirano, Fabio Marra.   

Abstract

Both alcoholic and nonalcoholic steatohepatitis are relevant causes of cirrhosis and liver-related mortality. Alcohol abuse represents a major health problem in many countries, and liver disease is considered one of the most relevant causes of death related to this factor. Nonalcoholic fatty liver disease is the most common hepatic abnormality in the Western world, and progresses to cirrhosis and hepatocellular carcinoma in a significant portion of cases. Moreover, presence of NAFLD is associated with an increased risk of cardiovascular events. In this review, we discuss the characteristics of fibrosis in alcoholic and nonalcoholic steatohepatitis, focussing on the diagnostic issues and predictive factors. In addition, the pathogenetic mechanisms responsible for appearance and progression of fibrosis in the two conditions are briefly discussed.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21497741     DOI: 10.1016/j.bpg.2011.02.010

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  22 in total

1.  Adipose tissue-liver axis in alcoholic liver disease.

Authors:  Zhi-Gang Wang; Xiao-Bing Dou; Zhan-Xiang Zhou; Zhen-Yuan Song
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 2.  Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease.

Authors:  Fernando Ezquer; Flavia Bruna; Sebastián Calligaris; Paulette Conget; Marcelo Ezquer
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 3.  Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic β cells and adipocytes.

Authors:  Caroline Tao; Angelica Sifuentes; William L Holland
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-11-15       Impact factor: 4.690

4.  An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Romina Lomonaco; Janet Chen; Kenneth Cusi
Journal:  Ther Adv Endocrinol Metab       Date:  2011-10       Impact factor: 3.565

Review 5.  Alcoholic liver disease: pathogenesis and new targets for therapy.

Authors:  José Altamirano; Ramón Bataller
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-09       Impact factor: 46.802

6.  Reproductive age-associated fibrosis in the stroma of the mammalian ovary.

Authors:  Shawn M Briley; Susmita Jasti; Jennifer M McCracken; Jessica E Hornick; Barbara Fegley; Michele T Pritchard; Francesca E Duncan
Journal:  Reproduction       Date:  2016-09       Impact factor: 3.906

Review 7.  New treatment options for alcoholic hepatitis.

Authors:  Saggere Muralikrishna Shasthry; Shiv Kumar Sarin
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

Review 8.  Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?

Authors:  Michele T Pritchard; Jennifer M McCracken
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 9.  Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment.

Authors:  Johannes Weiß; Monika Rau; Andreas Geier
Journal:  Dtsch Arztebl Int       Date:  2014-06-27       Impact factor: 5.594

10.  Molecular mechanism of alcoholic fatty liver.

Authors:  Karuna Rasineni; Carol A Casey
Journal:  Indian J Pharmacol       Date:  2012-05       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.